Results 121 to 130 of about 113,982,624 (231)

IgA nephropathy, non-cirrhotic portal fibrosis, and POEMS syndrome: A rare combination in the long-term follow-up of Sjögren’s syndrome

open access: yesJournal of International Medical Research
Sjögren’s syndrome is a heterogeneous autoimmune disorder that may be associated with systemic manifestations involving multiple organs. We herein reported a rare combination of immunoglobulin A nephropathy; non-cirrhotic portal fibrosis; and ...
Xiuhong Wang   +6 more
doaj   +1 more source

Immature Neutrophil Phenotype and Enhanced Myeloperoxidase in Male Patients With Chronic Kidney Disease and Cardiovascular Comorbidity

open access: yesActa Physiologica, Volume 242, Issue 9, September 2026.
ABSTRACT Aim Patients with chronic kidney disease (CKD) have an increased cardiovascular risk. Since neutrophils and neutrophil‐borne proteins contribute to cardiovascular disease, we analyzed the neutrophil phenotype in patients with CKD who presented with a spectrum of cardiovascular comorbidities.
Sonja Vondenhoff   +22 more
wiley   +1 more source

Involvement of Bacterial Antigens in Immunoglobulin A Nephropathy [PDF]

open access: yes, 1996
To investigate the involvement of bacterial antigens in Immunoglobulin A (IgA) nephropathy, we measured IgA, IgG and IgM antibodies to gram-negative Escherichia coli (E.coli) and Haemophilus influenzae (H.influenzae) by ELISA in 24 patients (11 males and
Sekiguchi, Yoshitaka   +6 more
core  

Cancer in IgA nephropathy; a letter to the editor on current findings [PDF]

open access: yesJournal of Nephropharmacology
Maryam ALem   +5 more
doaj   +1 more source

IgA nephropathy in a child with X-linked agammaglobulinemia: a case report

open access: yesBMC Pediatrics
Background X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused by mutations in the Bruton tyrosine kinase (BTK) gene. Individuals diagnosed with XLA are at an increased risk of developing autoimmune diseases.
Yuanjin Song   +4 more
doaj   +1 more source

Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 9, Page 1524-1532, September 2026.
This real‐world observational study enrolled 256 patients with type 2 diabetes and chronic kidney disease (T2D‐CKD). After 12 months of finerenone treatment, 45 patients completed follow‐up. Finerenone was associated with significant improvements in insulin resistance markers (HOMA‐IR, TyG index), lipid profile (LDL‐C), glycemic control (HbA1c), and ...
Xin Zhao   +4 more
wiley   +1 more source

The utility of glomerular C4d immunostaining in renal biopsies in patients with immunoglobulin A nephropathy. A clinicopathological study

open access: yes, 2017
The course of IgA nephropathy (IgAN) is highly variable and ranges from a totally benign condition to end-stage renal disease in approximately one third of cases.
Małgorzata Wągrowska-Danilewicz   +1 more
core   +1 more source

A multicenter retrospective cohort study on the efficacy and safety of mycophenolate mofetil plus hydroxychloroquine therapy in IgA nephropathy

open access: yesFrontiers in Immunology
BackgroundThe mechanisms of action of mycophenolate mofetil (MMF) and hydroxychloroquine (HCQ) differ in the treatment of IgA nephropathy (IgAN), and the two may have a synergistic effect in delaying disease progression.MethodsThis multicenter ...
Yang Yang   +10 more
doaj   +1 more source

Immunological and genetic factors associated with type 1 diabetic nephropathy [PDF]

open access: yes, 2000
Väitöskirjaei tietoa saavutettavuudesta unknown ...
Korpinen, Eija
core  

Disease modification in immunoglobulin A nephropathy

open access: yesNephrology Dialysis Transplantation
ABSTRACT With the rapidly expanding therapeutic landscape in IgA nephropathy, that incorporates new drugs with varied mechanisms of action, many of which may lead to modification of the fundamental pathophysiology of the world's commonest glomerular disease, thoughts are now turning to how we should define disease modification in IgA ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy